[Central serous chorioretinopathy as a complication of epitheliopathy under treatment with glucocorticoids].
METHODS
We present cases of two patients who were examined in our department with the diagnosis of epitheliopathy following treatment with oral and topical glucocorticoids. They were referred because of loss of visual acuity. The ophthalmic examination established the diagnosis of central serous chorioretinopathy and it was decided to stop treatment with glucocorticoids.


CONCLUSIONS
The pathogenesis of the central serous chorioretinopathy is still imprecisely known, but it has been related to several situations characterized by exposure to high levels of endogenous or exogenous glucocorticoids. Both of these cases provide more evidence of the potential association between corticosteroids and the acute manifestations of central serous chorioretinopathy.
Fernández Hortelano
A
A
Departamento de Oftalmología, Clínica Universitaria de Navarra, 31008 Pamplona, España. anaferh@unav.es
Sádaba
L M
LM
Heras Mulero
H
H
García Layana
A
A
D015862:Choroid Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012164:Retinal Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D041623:Tomography, Optical Coherence
D005938:Glucocorticoids